Literature DB >> 10821843

Genomic and functional changes induced by the activation of the peripheral cannabinoid receptor CB2 in the promyelocytic cells HL-60. Possible involvement of the CB2 receptor in cell differentiation.

J M Derocq1, O Jbilo, M Bouaboula, M Ségui, C Clère, P Casellas.   

Abstract

The function of the peripheral cannabinoid receptor (CB2), which is mainly expressed on hematopoietic cells, remains an enigma. In an attempt to decipher its role, we used Affymetrix DNA chips to investigate the gene expression profile of the promyelocytic cells HL-60 transfected with the CB2 receptor and activated with the cannabinoid agonist CP 55,940. Agonist exposure of these cells led to an activation of a mitogen-activated protein kinase cascade and a receptor desensitization, indicating a functional coupling of the transfected receptors. At the genomic level, activation of the CB2 receptors induced an up-regulation of nine genes involved in cytokine synthesis, regulation of transcription, and cell differentiation. A majority of them are under the control of the transcription factor NF-kappaB, whose nuclear translocation was demonstrated. Many features of the transcriptional events, reported here for the first time, appeared to be related to an activation of a cell differentiation program, suggesting that CB2 receptors could play a role in the initialization of cell maturation. Moreover, we showed that CB2-activated wild-type HL-60 cells developed properties usually found in host defense effector cells such as an enhanced release of chemotactic cytokines and an increased motility, characteristic of more mature cells of the granulocytic-monocytic lineage.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10821843     DOI: 10.1074/jbc.275.21.15621

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

Review 1.  Microbial infections, immunomodulation, and drugs of abuse.

Authors:  Herman Friedman; Catherine Newton; Thomas W Klein
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

2.  A glial endogenous cannabinoid system is upregulated in the brains of macaques with simian immunodeficiency virus-induced encephalitis.

Authors:  Cristina Benito; Woong-Ki Kim; Wong-Ki Kim; Iván Chavarría; Ceceila J Hillard; Ken Mackie; Rosa M Tolón; Kenneth Williams; Ken Williams; Julián Romero
Journal:  J Neurosci       Date:  2005-03-09       Impact factor: 6.167

Review 3.  Cannabinoid receptors and endocannabinoids: evidence for new players.

Authors:  Ken Mackie; Nephi Stella
Journal:  AAPS J       Date:  2006-04-28       Impact factor: 4.009

Review 4.  The complications of promiscuity: endocannabinoid action and metabolism.

Authors:  S P H Alexander; D A Kendall
Journal:  Br J Pharmacol       Date:  2007-09-17       Impact factor: 8.739

5.  The orphan receptor GPR55 is a novel cannabinoid receptor.

Authors:  E Ryberg; N Larsson; S Sjögren; S Hjorth; N-O Hermansson; J Leonova; T Elebring; K Nilsson; T Drmota; P J Greasley
Journal:  Br J Pharmacol       Date:  2007-09-17       Impact factor: 8.739

6.  The endocannabinoid system and pivotal role of the CB2 receptor in mouse spermatogenesis.

Authors:  Paola Grimaldi; Pierangelo Orlando; Sara Di Siena; Francesca Lolicato; Stefania Petrosino; Tiziana Bisogno; Raffaele Geremia; Luciano De Petrocellis; Vincenzo Di Marzo
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-18       Impact factor: 11.205

7.  Targeting cannabinoid receptor CB(2) in cardiovascular disorders: promises and controversies.

Authors:  Sabine Steffens; Pál Pacher
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

Review 8.  Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas.

Authors:  Nephi Stella
Journal:  Glia       Date:  2010-07       Impact factor: 7.452

Review 9.  Cannabinoids and neuroinflammation.

Authors:  Lisa Walter; Nephi Stella
Journal:  Br J Pharmacol       Date:  2004-02-02       Impact factor: 8.739

10.  Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosis.

Authors:  Vanessa Deveaux; Thomas Cadoudal; Yasukatsu Ichigotani; Fatima Teixeira-Clerc; Alexandre Louvet; Sylvie Manin; Jeanne Tran-Van Nhieu; Marie Pierre Belot; Andreas Zimmer; Patrick Even; Patrice D Cani; Claude Knauf; Remy Burcelin; Adeline Bertola; Yannick Le Marchand-Brustel; Philippe Gual; Ariane Mallat; Sophie Lotersztajn
Journal:  PLoS One       Date:  2009-06-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.